EXICOOL
Main information
- Trade name:
- EXICOOL 100 ML LOT
- Active ingredient:
- Calamine,Zinc Oxide,Bentonite,Glycerine,Sod.Cit.,Liq.Phenol
- Available from:
- ADMIT
- Dosage:
- 15,5,3,5;%
- Pharmaceutical form:
- LOT
- Composition:
- 100 ML
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
6-7-2017
The European Commission's decision concerning veterinary medicinal products containing zinc oxide
On 26 June 2017, the European Commission adopted a decision to withdraw all marketing authorisations for veterinary medicinal products containing zinc oxide administered orally to food producing species. The medicinal products affected by the decision appear from Annex I to the decision.
Danish Medicines Agency
21-3-2017
New recommendation for phasing out zinc oxide for young pigs
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has confirmed a previous decision to phase out zinc oxide. Consequently, the CVMP has once more recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.
Danish Medicines Agency
5-1-2017
Re-examination of the CVMP's decision to phase out zinc oxide for young pigs
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) will re-examine the decision to phase out medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs.
Danish Medicines Agency
19-12-2016
Zinc oxide for young pigs to be phased out
The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has recommended to the European Commission that medicinal products containing zinc oxide for the prevention of diarrhoea in young pigs should be withdrawn from the market.
Danish Medicines Agency
There are no news related to this product.